Aug 152016
Talent4Boards - Great Talent builds Great Boards
– USA, CA – Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced that Faheem Hasnain has been appointed to its Board of Directors, effective immediately.… => Read more
Vital Therapies appoints Faheem Hasnain to its Board of Directors
From:: Vital Therapies appoints Faheem Hasnain to its Board of Directors
Sorry, the comment form is closed at this time.